Transcutaneous Electrical Nerve Stimulation With Frequency Specific Microcurrent Resonance Therapy for Non Specific Chronic Low Back Pain Patents: a Prospective Double Blinded, Randomized, Placebo Control Trial
CompletedNot applicableNCT04617197
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Transcutaneous electrical nerve stimulation (TENS) is widely used for chronic pain. Recent studies showed frequency-specific microcurrent (FSM) resonant therapy was safe and effective in patients with non-specific chronic low back pain. However, there was no prospective, double-blinded randomized controlled trial to validate the clinical applicability. The goal of this trial is to verify safety and efficacy of FSM using a TENS device, Dragon Waves Resonant Home Care Electronic Nerve Stimulator-DW1330,(Taiwan Resonant Waves Research Co, Taiwan R.O.C), in 60 patients with non-specific low back pain.
Study details
- Official title
- Transcutaneous Electrical Nerve Stimulation With Frequency Specific Microcurrent Resonance Therapy for Non Specific Chronic Low Back Pain Patents: a Prospective Double Blinded, Randomized, Placebo Control Trial
- Conditions
- Interventions
- Device: Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy
- Sponsor
- Taipei Medical University
- Collaborators
- Taiwan Resonant Waves Research Corp.
- Start date
- 2020-09-01
- Primary completion
- 2021-03-31
- Sex
- All
- Age range
- from 20 Years to 80 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Taiwan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age between 20-80 years old, male or female. 2. Cases with normal psychological and communication functions who can cooperate with our study. 3. Cases who are willing to sign permits and cooperate with our study including follow up and examination. 4. Cases with complete clinical data and willing to accept investigation. Exclusion Criteria: 1. Cases who diagnose pregnancy within 12 months before included. 2. Cases who diagnose with malignant disease. 3. Cases with a history of epilepsy. 4. Cases who diagnose with fracture without fixation. 5. Cases who diagnose with impaired sensation or psychological function. 6. Cases whose skin condition is not feasible to accept treatment. 7. Cases with pacemaker. 8. Cases who allergic to the conductive medium 9. Cases with a major psychiatric disorder such as schizophrenia or bipolar disorder. 10. Cases with severe visual or auditory disorder. 11. Cases who cannot communicate with the Mandarin language. 12. Other mental diseases are not suitable assessed by the PI
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04617197